slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,471
Current window 34,981-35,010
Pages 3,950
Rows per page 30
Component
34,981-35,010 of 118,471
14
The slide uses federal procurement data to suggest Oxford Ionics had advanced to the second round of a DARPA competition by July 2025, contradicting the narrative of IONQ's acquisition timing.IonQ Inc. (IONQ) · Wolfpack Research
Research note Short seller Beat · The Struggle2 hits
17
The slide uses a testimonial as evidence of the lobbying relationship. It highlights specific financial figures ($3 million in fees, $2,900 campaign contribution).IonQ Inc. (IONQ) · Wolfpack Research
Research note Short seller Beat · The Victory2 hits
19
The table highlights the discrepancy between Congressional earmark language and the resulting procurement contracts, suggesting a 'backdoor' funding mechanism.IonQ Inc. (IONQ) · Wolfpack Research
Research note Short seller Beat · The Victory2 hits
03
The slide uses anecdotal evidence from former employees and financial data to challenge the company's narrative.Innodata, Inc. (INOD) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction2 hits
07
Uses a dialogue-based format to contrast management's public statements with internal reality.Innodata, Inc. (INOD) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction2 hits
01
This is a short-seller research note from Wolfpack Research.Qutoutiao, Inc. (QTT) · Wolfpack Research
Research note Short seller 2 hits
07
This is a research note from Wolfpack Research attacking QTT's acquisition of Dianguan.Qutoutiao, Inc. (QTT) · Wolfpack Research
Research note Short seller 2 hits
12
The slide uses a combination of tables and narrative to build a case for financial misrepresentation.Qutoutiao, Inc. (QTT) · Wolfpack Research
Research note Short seller 2 hits
13
This is a page from a research report (Page 13 of 23). It uses a 'preempt_rebuttal' and 'expose_contradiction' approach to dismantle QTT's defense of its loyalty program.Qutoutiao, Inc. (QTT) · Wolfpack Research
Research note Short seller 2 hits
19
The slide serves as a direct rebuttal to a company response, focusing on technical incompetence and potential fraud.Qutoutiao, Inc. (QTT) · Wolfpack Research
Research note Short seller 2 hits
02
This is a page from a short-seller research report (likely Wolfpack Research on EHang).EHang Holdings, Ltd. (EH) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction2 hits
04
This is a short-seller research note excerpt highlighting legal jeopardy.EHang Holdings, Ltd. (EH) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction2 hits
05
Short-seller research note style; uses photographic evidence to debunk corporate claims.EHang Holdings, Ltd. (EH) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction2 hits
10
Uses visual evidence to undermine the credibility of the subject company's manufacturing capabilities.EHang Holdings, Ltd. (EH) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction2 hits
12
The slide uses visual evidence (photos) to debunk a specific claim made by 'EH'.EHang Holdings, Ltd. (EH) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction2 hits
13
The slide uses visual evidence (photo) to contradict claims of manufacturing capability and highlights financial risk via a footnote citation.EHang Holdings, Ltd. (EH) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction2 hits
14
The slide presents a dialogue between an analyst (WP) and an expert (MM) to discredit EHang's technical capabilities.EHang Holdings, Ltd. (EH) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction2 hits
19
The slide uses excerpts from SEC filings to expose potential fraudulent or inflated revenue reporting.EHang Holdings, Ltd. (EH) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction2 hits
21
Short-seller research note style; uses aggressive language ('abhorrently high', 'fabricated sales').EHang Holdings, Ltd. (EH) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction2 hits
28
The slide uses a two-part argument structure ('First', 'Second') to establish the importance of the entity and the severity of the legal action.EHang Holdings, Ltd. (EH) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction2 hits
06
The slide details how SGH benefited from government-mandated local content requirements, which created artificial demand and pricing power until the rules changed in 2019.SMART Global Holdings, Inc. (SGH) · Wolfpack Research
Research note Short seller Loop · Logic Chain2 hits
16
The slide uses dual-axis charts to correlate revenue with profitability metrics to support a bearish thesis on SGH.SMART Global Holdings, Inc. (SGH) · Wolfpack Research
Research note Short seller Loop · Aha Moment2 hits
18
The slide uses a 'before/after' narrative structure to highlight a strategic pivot forced by external regulatory pressure.SMART Global Holdings, Inc. (SGH) · Wolfpack Research
Research note Short seller Loop · Aha Moment2 hits
23
The slide uses official financial statement excerpts to support a thesis of a small, low-margin operation.SMART Global Holdings, Inc. (SGH) · Wolfpack Research
Research note Short seller 2 hits
04
The slide includes a visual critique of a Western blot image, highlighting misaligned wells as evidence of image manipulation.PMV Pharmaceuticals (PMVP) · Wolfpack Research
Research note Short seller Beat · The MonsterLoop · Aha Moment2 hits
05
The slide uses a combination of scientific critique (gel analysis) and quantitative data (bar chart) to challenge the validity of the company's preclinical findings.PMV Pharmaceuticals (PMVP) · Wolfpack Research
Research note Short seller Beat · The MonsterLoop · Aha Moment2 hits
06
The slide uses gene expression data (p21 and MDM2) to challenge the company's stated mechanism of action.PMV Pharmaceuticals (PMVP) · Wolfpack Research
Research note Short seller Beat · The MonsterLoop · Aha Moment2 hits
07
Uses dose conversion to humans as a comparative framework to highlight potential lack of potency/viability.PMV Pharmaceuticals (PMVP) · Wolfpack Research
Research note Short seller Beat · The MonsterLoop · Aha Moment2 hits
08
Includes a critique of data transparency regarding mouse model selection and survival metrics.PMV Pharmaceuticals (PMVP) · Wolfpack Research
Research note Short seller Beat · The MonsterLoop · Aha Moment2 hits
11
The slide uses a skeptical tone to challenge the efficacy of the drug based on the provided bar charts.PMV Pharmaceuticals (PMVP) · Wolfpack Research
Research note Short seller Beat · The Monster2 hits